Who Paid My Doc
Kevin Sullivan
Hematology & Oncology New York, NY
NPI 1881842722 CMS profile 312098
178 E 85Th St, 4Th Floor, New York, NY 10028
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Kevin Sullivan of New York, NY.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Prescribing to Medicare patients
Part D · data year 2024 · 13 drugsPart D claims
360
Drug cost
$1,693,759
Branded share of claims
40.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | Brand | 65 | $1,093,115 | |
| Gilotrif Afatinib Dimaleate | Brand | 27 | $312,170 | |
| Lumakras Sotorasib | Brand | 13 | $169,606 | |
| Erlotinib Hcl | Generic | 16 | $91,532 | |
| Eliquis Apixaban | Brand | 40 | $25,590 | |
| Dexamethasone | Generic | 48 | $625 | |
| Clindamycin Phosphate | Generic | 12 | $526 | |
| Metoclopramide Hcl | Generic | 53 | $214 | |
| Omeprazole | Generic | 16 | $97 | |
| Folic Acid | Generic | 28 | $93 |
The 10 drugs with the highest cost, of 13 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 8,746 Part D prescribers listed as Hematology-Oncology; they describe a distribution and say nothing about conduct.
Other Hematology & Oncology in New York
Michael Schuster
Hematology & Oncology · New York, NY
Charles Sawyers
Hematology & Oncology · New York, NY
Manuel Hidalgo-Medina
Hematology & Oncology · New York, NY
Francis Arena
Hematology & Oncology · Lake Success, NY
Sanjeev Jain
Hematology & Oncology · East Patchogue, NY
Ross Levine
Hematology & Oncology · New York, NY
Related records
Hematology & Oncology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Hematology & Oncology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.